Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 8—August 2022
Research

Factors Associated with Delayed or Missed Second-Dose mRNA COVID-19 Vaccination among Persons >12 Years of Age, United States

Lu Meng, Neil Chandra Murthy, Bhavini Patel Murthy, Elizabeth Zell, Ryan Saelee, Megan Irving, Hannah E. Fast, Patricia Castro Roman, Adam Schiller, Lauren Shaw, Carla L. Black, Lynn Gibbs-Scharf, LaTreace Harris, and Terence ChorbaComments to Author 
Author affiliations: Centers for Disease Control and Prevention Atlanta, Georgia, USA (L. Meng, N.C. Murthy, B.P. Murthy, E. Zell, R. Saelee, M. Irving, H.E. Fast, P.Castro Roman, A. Schiller, L. Shaw, C.L. Black, L. Gibbs-Scharf, L. Harris, T. Chorba); General Dynamics Information Technology Inc., Falls Church, Virginia, USA (L. Meng, R. Saelee); Stat-Epi Associates, Inc., Ponte Vedra Beach, Florida, USA (E. Zell); Deloitte Consulting LLP, New York, New York, USA (M. Irving); Booz Allen Hamilton, Inc., McLean, Virginia, USA (A. Schiller)

Main Article

Figure 2

States in each region used in study of factors associated with delayed or missed second-dose mRNA COVID-19 vaccination among persons >12 years of age, United States.

Figure 2. States in each region used in study of factors associated with delayed or missed second-dose mRNA COVID-19 vaccination among persons >12 years of age, United States.

Main Article

Page created: June 22, 2022
Page updated: July 20, 2022
Page reviewed: July 20, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external